Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 859.96 Million CNY | 65.49% |
| 2022 | 519.63 Million CNY | -16.32% |
| 2021 | 620.97 Million CNY | -32.86% |
| 2020 | 924.9 Million CNY | 146.45% |
| 2019 | 375.29 Million CNY | 38.92% |
| 2018 | 270.14 Million CNY | 451.38% |
| 2017 | -76.88 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 242.08 Million CNY | 1918.14% |
| 2024 Q1 | 38.58 Million CNY | -83.24% |
| 2024 Q2 | -13.31 Million CNY | -134.5% |
| 2023 Q1 | 93.96 Million CNY | 529.53% |
| 2023 FY | 859.96 Million CNY | 65.49% |
| 2023 Q4 | 230.25 Million CNY | -55.85% |
| 2023 Q3 | 521.49 Million CNY | 3559.12% |
| 2023 Q2 | 14.25 Million CNY | -84.83% |
| 2022 Q3 | 206.52 Million CNY | -30.94% |
| 2022 Q2 | 299.03 Million CNY | 35284.09% |
| 2022 Q1 | -849.91 Thousand CNY | -100.92% |
| 2022 FY | 519.63 Million CNY | -16.32% |
| 2022 Q4 | 14.92 Million CNY | -92.77% |
| 2021 Q1 | -4.12 Million CNY | -100.8% |
| 2021 Q4 | 92.8 Million CNY | -83.34% |
| 2021 Q3 | 557.14 Million CNY | 2341.51% |
| 2021 Q2 | -24.85 Million CNY | -502.67% |
| 2021 FY | 620.97 Million CNY | -32.86% |
| 2020 FY | 924.9 Million CNY | 146.45% |
| 2020 Q4 | 513.13 Million CNY | 17.11% |
| 2020 Q3 | 438.15 Million CNY | 10408.68% |
| 2020 Q2 | -4.25 Million CNY | 80.79% |
| 2020 Q1 | -22.12 Million CNY | 0.0% |
| 2019 FY | 375.29 Million CNY | 38.92% |
| 2018 FY | 270.14 Million CNY | 451.38% |
| 2017 FY | -76.88 Million CNY | 0.0% |